Literature DB >> 33629954

Open science takes on Parkinson's disease.

Ekemini Au Riley1, Randy Schekman1,2.   

Abstract

The Aligning Science Across Parkinson's (ASAP) initiative was set up to improve understanding of the biology underlying the onset and progression of Parkinson's disease. With an emphasis on open science and collaboration, we have assembled a research network led by nearly 100 investigators to explore the pathology of Parkinson's disease, and this network will soon expand to include researchers working on relevant (dys)-functional neural circuits. We have also contributed to large-scale genetics and patient cohort initiatives related to the disease. We hope that these actions, and others planned for the future, will deepen our knowledge of the molecular mechanisms underlying the origin and evolution of Parkinson's disease and, ultimately, contribute to the development of novel therapies.
© 2021, Riley and Schekman.

Entities:  

Keywords:  Parkinson's disease; collaboration; medicine; neurodegenerative disorders; neuroscience; none; open science; philanthropy; team science

Mesh:

Year:  2021        PMID: 33629954      PMCID: PMC7906598          DOI: 10.7554/eLife.66546

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  9 in total

Review 1.  The science of team science: A review of the empirical evidence and research gaps on collaboration in science.

Authors:  Kara L Hall; Amanda L Vogel; Grace C Huang; Katrina J Serrano; Elise L Rice; Sophia P Tsakraklides; Stephen M Fiore
Journal:  Am Psychol       Date:  2018 May-Jun

2.  Developing therapies for Parkinson's disease.

Authors: 
Journal:  Lancet Neurol       Date:  2020-09-16       Impact factor: 44.182

3.  The Missing Diversity in Human Genetic Studies.

Authors:  Giorgio Sirugo; Scott M Williams; Sarah A Tishkoff
Journal:  Cell       Date:  2019-03-21       Impact factor: 41.582

4.  Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies.

Authors:  Mike A Nalls; Cornelis Blauwendraat; Costanza L Vallerga; Karl Heilbron; Sara Bandres-Ciga; Diana Chang; Manuela Tan; Demis A Kia; Alastair J Noyce; Angli Xue; Jose Bras; Emily Young; Rainer von Coelln; Javier Simón-Sánchez; Claudia Schulte; Manu Sharma; Lynne Krohn; Lasse Pihlstrøm; Ari Siitonen; Hirotaka Iwaki; Hampton Leonard; Faraz Faghri; J Raphael Gibbs; Dena G Hernandez; Sonja W Scholz; Juan A Botia; Maria Martinez; Jean-Christophe Corvol; Suzanne Lesage; Joseph Jankovic; Lisa M Shulman; Margaret Sutherland; Pentti Tienari; Kari Majamaa; Mathias Toft; Ole A Andreassen; Tushar Bangale; Alexis Brice; Jian Yang; Ziv Gan-Or; Thomas Gasser; Peter Heutink; Joshua M Shulman; Nicholas W Wood; David A Hinds; John A Hardy; Huw R Morris; Jacob Gratten; Peter M Visscher; Robert R Graham; Andrew B Singleton
Journal:  Lancet Neurol       Date:  2019-12       Impact factor: 44.182

Review 5.  Finding useful biomarkers for Parkinson's disease.

Authors:  Alice S Chen-Plotkin; Roger Albin; Roy Alcalay; Debra Babcock; Vikram Bajaj; Dubois Bowman; Alex Buko; Jesse Cedarbaum; Daniel Chelsky; Mark R Cookson; Ted M Dawson; Richard Dewey; Tatiana Foroud; Mark Frasier; Dwight German; Katrina Gwinn; Xuemei Huang; Catherine Kopil; Thomas Kremer; Shirley Lasch; Ken Marek; Jarrod A Marto; Kalpana Merchant; Brit Mollenhauer; Anna Naito; Judith Potashkin; Alyssa Reimer; Liana S Rosenthal; Rachel Saunders-Pullman; Clemens R Scherzer; Todd Sherer; Andrew Singleton; Margaret Sutherland; Ines Thiele; Marcel van der Brug; Kendall Van Keuren-Jensen; David Vaillancourt; David Walt; Andrew West; Jing Zhang
Journal:  Sci Transl Med       Date:  2018-08-15       Impact factor: 17.956

6.  The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort.

Authors:  Kenneth Marek; Sohini Chowdhury; Andrew Siderowf; Shirley Lasch; Christopher S Coffey; Chelsea Caspell-Garcia; Tanya Simuni; Danna Jennings; Caroline M Tanner; John Q Trojanowski; Leslie M Shaw; John Seibyl; Norbert Schuff; Andrew Singleton; Karl Kieburtz; Arthur W Toga; Brit Mollenhauer; Doug Galasko; Lana M Chahine; Daniel Weintraub; Tatiana Foroud; Duygu Tosun-Turgut; Kathleen Poston; Vanessa Arnedo; Mark Frasier; Todd Sherer
Journal:  Ann Clin Transl Neurol       Date:  2018-10-31       Impact factor: 4.511

Review 7.  The Emerging Evidence of the Parkinson Pandemic.

Authors:  E Ray Dorsey; Todd Sherer; Michael S Okun; Bastiaan R Bloem
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

8.  Coordinating a new approach to basic research into Parkinson's disease.

Authors:  Randy Schekman; Ekemini Au Riley
Journal:  Elife       Date:  2019-09-25       Impact factor: 8.140

  9 in total
  3 in total

Review 1.  Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson's disease.

Authors:  Elena Coccia; Tim Ahfeldt
Journal:  Stem Cell Res Ther       Date:  2021-04-29       Impact factor: 6.832

2.  Multi-modality machine learning predicting Parkinson's disease.

Authors:  Mary B Makarious; Hampton L Leonard; Dan Vitale; Hirotaka Iwaki; Lana Sargent; Anant Dadu; Ivo Violich; Elizabeth Hutchins; David Saffo; Sara Bandres-Ciga; Jonggeol Jeff Kim; Yeajin Song; Melina Maleknia; Matt Bookman; Willy Nojopranoto; Roy H Campbell; Sayed Hadi Hashemi; Juan A Botia; John F Carter; David W Craig; Kendall Van Keuren-Jensen; Huw R Morris; John A Hardy; Cornelis Blauwendraat; Andrew B Singleton; Faraz Faghri; Mike A Nalls
Journal:  NPJ Parkinsons Dis       Date:  2022-04-01

3.  Black and African American Connections to Parkinson's Disease Study: Addressing Missing Diversity in Parkinson's Disease Genetics.

Authors:  Sara Bandres-Ciga
Journal:  Mov Disord       Date:  2022-04-30       Impact factor: 9.698

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.